358 related articles for article (PubMed ID: 21507897)
1. Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.
Morán-Salvador E; López-Parra M; García-Alonso V; Titos E; Martínez-Clemente M; González-Périz A; López-Vicario C; Barak Y; Arroyo V; Clària J
FASEB J; 2011 Aug; 25(8):2538-50. PubMed ID: 21507897
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.
Inoue M; Ohtake T; Motomura W; Takahashi N; Hosoki Y; Miyoshi S; Suzuki Y; Saito H; Kohgo Y; Okumura T
Biochem Biophys Res Commun; 2005 Oct; 336(1):215-22. PubMed ID: 16125673
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ.
Xu E; Forest MP; Schwab M; Avramoglu RK; St-Amand E; Caron AZ; Bellmann K; Shum M; Voisin G; Paquet M; Montoudis A; Lévy E; Siminovitch KA; Neel BG; Beauchemin N; Marette A
Hepatology; 2014 May; 59(5):1803-15. PubMed ID: 24327268
[TBL] [Abstract][Full Text] [Related]
5. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
Yu S; Viswakarma N; Batra SK; Sambasiva Rao M; Reddy JK
Biochimie; 2004 Nov; 86(11):743-61. PubMed ID: 15589683
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
7. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
Geng T; Xia L; Russo S; Kamara D; Cowart LA
Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
[TBL] [Abstract][Full Text] [Related]
8. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
10. PPARgamma is essential for protection against nonalcoholic steatohepatitis.
Wu CW; Chu ES; Lam CN; Cheng AS; Lee CW; Wong VW; Sung JJ; Yu J
Gene Ther; 2010 Jun; 17(6):790-8. PubMed ID: 20376096
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
[TBL] [Abstract][Full Text] [Related]
12. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.
Chen J; Wang W; Qi Y; Kaczorowski D; McCaughan GW; Gamble JR; Don AS; Gao X; Vadas MA; Xia P
Biochim Biophys Acta; 2016 Feb; 1861(2):138-147. PubMed ID: 26615875
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P
J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
[TBL] [Abstract][Full Text] [Related]
19. PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly.
Ye JM; Iglesias MA; Watson DG; Ellis B; Wood L; Jensen PB; Sørensen RV; Larsen PJ; Cooney GJ; Wassermann K; Kraegen EW
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E531-40. PubMed ID: 12556350
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity.
Lee SM; Muratalla J; Diaz-Ruiz A; Remon-Ruiz P; McCann M; Liew CW; Kineman RD; Cordoba-Chacon J
Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34417811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]